First-Line Antibiotic Treatment for Common Bacterial Infections
First-line antibiotic treatment for common bacterial infections should follow the WHO AWaRe (Access, Watch, Reserve) framework, with Access antibiotics as the preferred first choice for most common infections due to their favorable safety profiles, effectiveness, and lower risk of promoting antimicrobial resistance. 1
Understanding the AWaRe Framework
The WHO has categorized antibiotics into three groups to guide appropriate use:
- Access Group - First-line antibiotics that should be widely available, affordable, and of assured quality for common infections
- Watch Group - Antibiotics with higher resistance potential that should be targeted for stewardship programs
- Reserve Group - Last-resort antibiotics for multidrug-resistant infections
First-Line Treatments for Common Infections
Respiratory Tract Infections
Acute Otitis Media
- First choice: Amoxicillin (80-90 mg/kg/day in 2 divided doses) 1
- Alternative for penicillin allergy: Cefdinir, cefuroxime, or cefpodoxime 1
- If treatment failure or recent antibiotic use: Amoxicillin-clavulanate 1
Community-Acquired Pneumonia
- Children under 3 years: Amoxicillin 80-100 mg/kg/day in three daily doses 1
- Children over 3 years:
- Suspected pneumococcal: Amoxicillin
- Suspected atypical (Mycoplasma/Chlamydia): Macrolide 1
- Adults: Amoxicillin or amoxicillin-clavulanate depending on local resistance patterns 1
Urinary Tract Infections
- Uncomplicated: Trimethoprim-sulfamethoxazole or nitrofurantoin
- Complicated: Fluoroquinolones (e.g., levofloxacin) for adults, though these are Watch antibiotics and should be used judiciously 2
Skin and Soft Tissue Infections
- Uncomplicated: Cephalexin or dicloxacillin
- MRSA suspected: Trimethoprim-sulfamethoxazole or doxycycline 3
Sepsis
- First choice: Amoxicillin + gentamicin, ampicillin + gentamicin, or benzylpenicillin + gentamicin 1
- Second choice: Amikacin + cloxacillin, cefotaxime, or ceftriaxone 1
Key Considerations for Antibiotic Selection
Local Resistance Patterns
Antibiotic choices should be informed by local resistance patterns. For example, in areas with high rates of amoxicillin-resistant H. influenzae, amoxicillin-clavulanate may be preferred for respiratory infections 1.
Patient Factors
- Recent antibiotic use: Consider alternative class if patient has taken antibiotics in the previous 30 days 1
- Penicillin allergy: Second and third-generation cephalosporins (cefdinir, cefuroxime, cefpodoxime) have minimal cross-reactivity with penicillins and are safe alternatives 1
Severity of Infection
More severe infections may warrant broader-spectrum initial therapy to ensure coverage of likely pathogens while awaiting culture results 4.
Common Pitfalls to Avoid
Overuse of broad-spectrum antibiotics: Using unnecessarily broad-spectrum antibiotics contributes to antimicrobial resistance. Start with Access antibiotics when appropriate 1, 5.
Inappropriate duration: Treat for the shortest effective duration to minimize resistance development.
Ignoring local resistance patterns: Treatment choices should be adjusted based on local epidemiology and resistance patterns 1.
Failure to reassess: Empiric therapy should be reassessed when culture results become available to allow for targeted therapy.
Overlooking atypical pathogens: For respiratory infections, consider atypical pathogens (Mycoplasma, Chlamydia) that require macrolide coverage, especially in older children and adults 1.
By following these evidence-based recommendations and considering local resistance patterns, clinicians can optimize antibiotic selection for common bacterial infections while promoting antimicrobial stewardship.